Sponsored By

What Medtech CEOs Expect from the Second Half of the Year

Here's what the medtech industry can expect from the second half of 2021, based on CEO/CFO comments from recent earnings calls.

Amanda Pedersen

May 26, 2021

5 Slides

Since the beginning of the year, it seems, all eyes have been on the second half of 2021 as medtech companies were still grappling with a lot of uncertainty heading into 2021. Now that we're well into the second quarter, here are some key takeaways from first-quarter earnings calls from a handful of medtech companies that were most impacted by COVID-19 disruptions and lower procedure volumes.

About the Author(s)

Amanda Pedersen

Amanda Pedersen is a veteran journalist and award-winning columnist with a passion for helping medical device professionals connect the dots between the medtech news of the day and the bigger picture. She has been covering the medtech industry since 2006.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like